These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 34054270)

  • 1. l -Arginine Can Enhance the Beneficial Effect of Losartan in Patients with Chronic Aortic Regurgitation and Isolated Systolic Hypertension.
    Lin SL; Lin M; Wang KL; Kuo HW; Tak T
    Int J Angiol; 2021 Jun; 30(2):122-131. PubMed ID: 34054270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
    Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
    J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of losartan and metoprolol on left ventricular and aortic function at rest and during exercise in chronic aortic regurgitation.
    Roberts PA; Lin ACW; Cowan BR; Young AA; Stewart R
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):615-624. PubMed ID: 29119275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study).
    Mancusi C; Gerdts E; De Simone G; Abdelhai YM; Lønnebakken MT; Boman K; Wachtell K; Dahlöf B; Devereux RB
    Blood Press; 2014 Aug; 23(4):206-12. PubMed ID: 24564262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy.
    Lin M; Chiang HT; Lin SL; Chang MS; Chiang BN; Kuo HW; Cheitlin MD
    J Am Coll Cardiol; 1994 Oct; 24(4):1046-53. PubMed ID: 7930196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losartan reduces left ventricular hypertrophy proportionally to blood pressure reduction in hypertensives, but does not affect diastolic cardiac function.
    Zakynthinos E; Pierutsakos Ch; Konstantinidis K; Zakynthinos S; Papadogiannis D
    Angiology; 2004; 55(6):669-78. PubMed ID: 15547653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Left Ventricular Characteristics Assessed by Cardiac Magnetic Resonance Imaging and Cardiovascular Biomarkers Related to Kidney Transplantation.
    Prasad GVR; Yan AT; Nash MM; Kim SJ; Wald R; Wald R; Lok C; Gunaratnam L; Karur GR; Kirpalani A; Connelly PW
    Can J Kidney Health Dis; 2018; 5():2054358118809974. PubMed ID: 30542623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the blood pressure-lowering effects and tolerability of Losartan- and Amlodipine-based regimens in patients with isolated systolic hypertension.
    Volpe M; Junren Z; Maxwell T; Rodriguez A; Gamboa R; Gomez-Fernandez P; Ortega-Gonzalez G; Matadamas N; Rodriguez F; Dass B; Kyle C; Clarysse L; Bryce A; Moreno-Heredia E; Germano G; Gilles L; Smith RD; Sanderson JE;
    Clin Ther; 2003 May; 25(5):1469-89. PubMed ID: 12867222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Echocardiographic Left Ventricular End-Systolic Volume and Volume-Derived Ejection Fraction With Outcome in Asymptomatic Chronic Aortic Regurgitation.
    Yang LT; Anand V; Zambito EI; Pellikka PA; Scott CG; Thapa P; Padang R; Takeuchi M; Nishimura RA; Enriquez-Sarano M; Michelena HI
    JAMA Cardiol; 2021 Feb; 6(2):189-198. PubMed ID: 33146680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan improves regional left ventricular systolic and diastolic function in patients with hypertension: accurate evaluation using a newly developed color-coded tissue doppler imaging technique.
    Tanaka H; Oki T; Tabata T; Yamada H; Harada K; Kimura E; Oishi Y; Ishimoto T; Ito S
    J Card Fail; 2004 Oct; 10(5):412-20. PubMed ID: 15470652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin II receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients.
    Cuspidi C; Meani S; Valerio C; Fusi V; Sala C; Maisaidi M; Zanchetti A
    Blood Press; 2006; 15(2):107-15. PubMed ID: 16754274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of losartan on exercise tolerance and echocardiographic parameters in patients with mitral regurgitation.
    Sekuri C; Utuk O; Bayturan O; Bilge A; Kurhan Z; Tavli T
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):107-11. PubMed ID: 18584587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of heart rate variability and smoothness index on the reversal of hypertensive left ventricular hypertrophy].
    Wang HB; Shi Q; Zhang C
    Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(12):832-5. PubMed ID: 21600164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study.
    Palmieri V; Wachtell K; Gerdts E; Bella JN; Papademetriou V; Tuxen C; Nieminen MS; Dahlöf B; de Simone G; Devereux RB
    Am Heart J; 2001 May; 141(5):784-91. PubMed ID: 11320367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of losartan + L-arginine on nitric oxide production, endothelial cell function, and hemodynamic variables in patients with heart failure secondary to coronary heart disease.
    Koifman B; Topilski I; Megidish R; Zelmanovich L; Chernihovsky T; Bykhovsy E; Keren G
    Am J Cardiol; 2006 Jul; 98(2):172-7. PubMed ID: 16828587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study.
    Devereux RB; Palmieri V; Liu JE; Wachtell K; Bella JN; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Dahlöf B
    J Hypertens; 2002 Jul; 20(7):1445-50. PubMed ID: 12131543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Antihypertensive Treatment in Stage I Hypertension. Results From the Prever-Treatment Study.
    Bertoluci C; Foppa M; Santos ABS; Branchi TV; Fuchs SC; Fuchs FD
    Am J Hypertens; 2018 Feb; 31(3):321-328. PubMed ID: 29036504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
    Sato K; Kumar A; Jones BM; Mick SL; Krishnaswamy A; Grimm RA; Desai MY; Griffin BP; Rodriguez LL; Kapadia SR; Obuchowski NA; Popović ZB
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.